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The oral mucosa is a critical barrier tissue that harbors a series of distinct immune cell 
subsets. Immune surveillance in the oral mucosa is important for both local and systemic 
immunity because the oral cavity is a heavily utilized route of pathogen entry and also 
serves as site of pathogen propagation. Nonetheless, composition and phenotype of 
the lymphocyte pool in the oral mucosa have remained poorly characterized. Utilizing a 
newly established protocol for mucosal immune cell isolation, here, we report that the 
oral mucosa features a unique cellular composition of immune cells, which differed not 
only from secondary lymphoid organs but also from mucosal tissues in the gut and lung. 
We observed profound accumulation of CD11b+Ly6Clo monocytes in the oral mucosa 
that were maintained independently of T- and B-lymphocytes. Unlike the gut mucosa, 
the oral mucosa neither contained CD8αα T cells nor was it enriched for CD103+CD69+ 
tissue-resident memory CD8 T cells. In fact, a major fraction of T cells circulated and 
trafficked through the mucosa as revealed by treatment with the S1P1 receptor antag-
onist, FTY720, a potent inhibitor of lymphocyte migration. Collectively, these results 
provide a comprehensive picture of immune cells in the oral mucosa as an active site of 
lymphocyte recruitment and surveillance.
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inTrODUcTiOn
The oral cavity is one of the most frequently exposed sites to foreign antigens as it constantly encoun-
ters food-borne, water-borne, and air-borne antigens and other environmental insults (1–3). As 
such, it is astonishing that the oral cavity is normally absent of inflammation, and that fungal and 
other microbiological infections rarely happen under steady-state conditions (4). Multiple pathways 
have been attributed to achieve this feature, including production of antimicrobial peptides, expres-
sion of proteolytic enzymes, and also antibody secretion (5–8). As another major mechanism, it is 
understood that the oral mucosa, which lines the oral cavity, serves as a highly effective barrier tissue 
to filter and fight foreign pathogens and that it also suppresses overt and excessive immune reactions 
to maintain an effective but quiescent immune system (4, 9).
The oral mucosa is composed of two structural layers: the outer epithelium and the underlying 
lamina propria (LP) (10). While the epithelium primarily serves as a physical and chemical barrier, 
immune cells scattered through the epithelium and LP constitute an immunological barrier that 
scavenges invading microbes/antigens and initiates protective immune reactions (11, 12). Immune 
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surveillance in the oral mucosa is orchestrated by interplay of 
tissue-resident and migratory cells that triggers humoral and cel-
lular immune responses by lymphocytes and other hematopoietic 
origin cells. Conventionally, resident cells in the mucosa are 
understood as cells of stromal origin, such as gingival keratino-
cytes, fibroblasts, and also periodontal ligament cells. Migratory 
cells, on the other hand, are primarily of lymphoid origin and 
also include circulating granulocytes, such as neutrophils (13). 
However, with the identification of tissue-resident memory 
T cells (14–16), and the discovery of migratory CD103+ dendritic 
cells in non-lymphoid tissues (17), the partition into migratory 
and resident cells has become less clear.
While the characteristics of antigen presenting cells (APCs) 
in the oral mucosa, such as Langerhans cells, dendritic cells, and 
macrophages, have been studied to some extent (18–22), our 
knowledge on the cellular composition of immune cells and tissue 
residency of lymphoid cells in the oral mucosa remains limited. 
A major obstacle to address these issues has been the failure to 
efficiently recover immune cells that are embedded in the LP.
In this study, we describe a new cell isolation protocol that 
was used to recover T- and B-lymphocytes from the LP of the 
oral mucosa and to analyze their phenotype and tissue residency. 
The oral mucosa displayed a unique composition of lymphocytes 
and myeloid cells, which was highly enriched in CD11b+Ly6Clo 
monocytes, showed paucity of invariant NKT (iNKT) cells, and 
displayed preferential accumulation of CD4 T cells. Specifically, 
we identified a population of CD103+CD69+ CD4 T  cells that 
resembled tissue-resident CD8 memory T cells in the gut (16). 
Notably, CD8αα T cells were non-detectable and CD103+CD69+ 
CD8 T  cells were significantly reduced, demonstrating funda-
mental differences between lymphocytes in the oral and the gut 
mucosa. Collectively, these data provide a comprehensive picture 
of the immune landscape in the oral mucosa and report an effec-
tive protocol for immune cell isolation that can be used to further 
address immune cell function in the oral cavity.
MaTerials anD MeThODs
Mice
C57BL/6 (B6) mice were obtained from Charles River. Rag-
deficient (RAGKO) mice were purchased from the Jackson 
Laboratory. Animal experiments were performed with 8- to 
14-week-old mice of both sexes. All animal experiments were 
approved by the NCI Animal Care and Use Committee, and all 
mice were cared for in accordance with NIH guidelines.
Flow cytometry
Data were acquired on LSR Fortessa or LSRII flow cytometers 
(BD Biosciences) and analyzed using FlowJo and softwares 
designed by the Division of Computer Research and Technology, 
NCI. Live cells were gated using forward scatter exclusion of 
dead cells stained with propidium iodide. The following antibod-
ies were used for staining: TCRβ (H57-597), B220 (RA3-6B2), 
NK1.1 (PK136), CD11b (M1/70), CD44 (IM7), CD103 (2E7), 
and CD69 (H1.2F3), all from eBioscience; CD3 (2C11), CD4 
(GK1.5), CD8α (53-6-7), TCRγδ (GL3), and CD11c (HL3), all 
from BD Biosciences; and CD45 (30-F11), CD8β (YTS156.7.7), 
and Ly6C (HK1.4) from BioLegend. CD1d tetramers loaded 
with PBS-57 and unloaded controls were obtained from the NIH 
tetramer facility (Emory University, Atlanta, GA, USA).
leukocyte isolation
Liberase DL (dispase low), DH (dispase high), TL (thermolysin 
low), TM (thermolysin medium), and TH (thermolysin high) 
were purchased from Roche, and Collagenase IV from Gibco. 
Oral mucosal tissues were dissected from the buccogingival, sub-
lingual, palatal areas, and tongue (Figure S1A in Supplementary 
Material). The average weight of extracted oral mucosa tissue 
per mouse was 0.201 ± 0.006 g. Tissues from oral mucosa were 
processed by finely chopping and enzyme digesting with Liberase 
(0.5 mg/ml) or collagenase IV (1.0 mg/ml) at 37°C for 40 min 
under continuous rotation. For leukocyte isolation by the stag-
gered enzyme digestion method (SDTL), tissues were first treated 
with Liberase DL (0.5 mg/ml) for 20 min followed by Liberase TL 
(0.25 mg/ml) for another 20 min. Thus, total incubation time for 
Liberase DL was 40 min, while Liberase TL digestion was only for 
20 min (Figure S2 in Supplementary Material). Protease reaction 
was stopped by addition of EDTA (1 mM), and digested tissues 
were filtered through a 70-μm cell strainer (BD Biosciences). 
Collected cells were passed through a density gradient with 40 
and 70% Percoll (GE Healthcare) for 25 min at 2,200 rpm with 
no brake. Lymphocytes accumulated at the interphase, and cells 
were harvested, washed, and resuspended in cell culture media 
before further analysis. Small intestine intraepithelial leukocytes 
(SI IELs) were isolated as previously described (23). For isola-
tion of lung mononuclear cells, lungs were harvested after PBS 
perfusion, diced into pieces, and treated identical to oral mucosa 
tissues but using collagenase IV (1.0 mg/ml).
FTY720 injection
Sex- and age-matched B6 mice were given intraperitoneal injec-
tions of 125 μg of FTY720 (Cayman Chemical), three times a 
week for 2 weeks. Mice were sacrificed 24 h after the last injection 
for analysis.
statistical analysis
Data are shown as mean ±  SEM. Two-tailed Mann–Whitney 
U-test was used to calculate P-values between the two groups. 
One-way ANOVA with multiple comparisons was used to com-
pare means among more than three different groups. *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001 were considered statistically significant 
(NS, not significant).
resUlTs
Optimized Protocol for lymphocyte 
isolation from the Oral Mucosa
Conventional methods for cell isolation from tissues are 
plagued by low efficiency and biased recovery against certain 
lymphocyte subsets (24). Thus, we first aimed to improve the 
recovery and efficiency of conventional isolation protocols 
for oral mucosa lymphocytes (25). To do so, we experimented 
FigUre 1 | Optimized leukocyte isolation from the lamina propria of the oral mucosa. CD45+ cell frequencies (a) and numbers (B) in oral mucosa isolates 
that were processed using different proteolytic enzymes. Isolation efficiencies of Liberase (0.5 mg/ml) supplemented with different concentrations of either dispase 
(L.DL, L.DH) or thermolysin (L.TL, L.TM, L.TH) were compared to that of conventional collagenase IV (C.IV, 1.0 mg/ml) treatment. Tissues were incubated with each 
enzyme for 40 min. Results show mean ± SEM of 16 B6 mice in three independent experiments. (c) Cell surface B220 and TCRβ expression on oral mucosa 
isolates that were processed using different combinations of proteolytic enzymes. Results are representative of three independent experiments. Cell numbers were 
determined after isolation from the oral mucosa using the staggered Liberase DL and TL digestion (SDTL) or C.IV treatment. Panels (D,e) indicate numbers of total 
and CD45+-gated live (propidium iodide-negative) cells. Results show mean ± SEM of 11 mice with SDTL and 8 mice with C.IV digestion in three independent 
experiments.
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with different concentrations and combinations of proteolytic 
enzymes and found a highly purified mixture of collagenase 
I and II, i.e., Liberase (Roche Life Science), to be highly 
effective in digesting oral tissues. Importantly, addition of 
the neutral proteases dispase and thermolysin significantly 
increased the efficacy of Liberase (Figures 1A,B). However, 
co-treatment with high concentrations of thermolysin 
induced a dramatic loss of surface B220 antigens and other 
surface proteins, such as CD4 coreceptors (Figure  1C and 
data not shown), so that we limited the use of thermolysin to 
low concentration and short incubation time. Moreover, we 
found that a staggered treatment of Liberase digestion, first, 
in addition to low concentration of dispase (L.DL) followed 
by addition of low concentration of thermolysin (L.TL), 
resulted in the most efficient recovery of CD45+ hematopoi-
etic origin cells and increased numbers from the oral mucosa 
(Figures 1D,E; Figure S1B in Supplementary Material). This 
new protocol of low dosage dispase and thermolysin stag-
gered treatment, which we refer to as SDTL method (Figure 
S2 in Supplementary Material), still induced degradation 
of some proteolysis-sensitive molecules, such as CD62L 
(Figure S1C in Supplementary Material) (26). Nonetheless, 
we found SDTL method consistently and reproducibly supe-
rior to conventional methods regarding viability and cell 
recovery of CD45+ hematopoietic cells from the oral mucosa 
(Figures 1D,E). Collectively, this new method permitted us 
to assess the lymphocyte composition of the oral mucosa in a 
highly effective and reproducible manner.
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lymphocyte subsets in the Oral Mucosa
Compared to lymphocytes isolated from the spleen, we found a 
modest decrease in B220+ B lineage lymphocytes and a marked 
decrease in CD3+ T lineage cells among CD45+ cells in the 
oral mucosa (Figure 2A). In fact, the oral mucosa contained a 
significantly lower fraction of αβ T cells compared to secondary 
lymphoid organs (SLOs), such as spleen and lymph node (LN) 
(Figure 2B). The loss was more pronounced for CD8 T cells so 
that the CD4/CD8 ratio in the oral mucosa was the highest among 
analyzed tissues (Figure 2B, bottom). These data indicated a pref-
erence for CD4 T cells in the oral mucosa which contrasted to the 
mucosal tissue of the small intestine, where CD8 T cells preferen-
tially accumulate (Figure 2C, top) (16). Notably, the increase of 
CD8 T cells among SI IEL was due to the accumulation of CD8αα 
T cells and was specific to the gut mucosa (Figure 2C, bottom). 
Indeed, comparative analysis of the oral mucosa to the lung, 
which represents another protective mucosal tissue where T cells 
reside (Figure S3A in Supplementary Material) (27), showed that 
both oral and lung mucosal tissues contained lower frequencies 
of CD8 T cells relative to spleen and gut mucosa (Figure S3B in 
Supplementary Material).
Interestingly, we also found that iNKT cells were absent from 
the oral mucosa. This was quite surprising as iNKT cells are easily 
found in most, if not all tissues, including lung, liver, fat tissues, 
and also in all SLOs (Figure 2D) (28, 29). In comparison, other 
lymphocyte subsets, such as γδ T cells and NK cells, were present 
in significant numbers in the oral mucosa (Figure  2E), so the 
paucity of iNKT cells is selective. The biological significance of 
iNKT cell exclusion from the oral mucosa is not yet clear to us.
Myleoid cell subsets in the Oral Mucosa
Myleoid-origin monocytes, dendritic cells, and macrophages 
have been previously described in the oral mucosa, but frequen-
cies of individual subsets varied dramatically among studies (9, 
18, 30). In the current study, we identified myeloid cells only 
among CD45+-gated cells, which stratified the myeloid origin 
subsets for better identification and enumeration. We found that 
the non-B, non-T fraction of the oral mucosa harbored a large 
population of CD11b+ cells, which comprised macrophages and 
dendritic cells (Figures 3A,B) (31). Enrichment in dendritic cells 
was further confirmed by the concomitant increase of CD11c+ 
cells (Figure 3A, top; Figure 3B), which is an established marker 
for dendritic cells. Importantly, using surface expression of Ly6C, 
we were able to further delineate CD11b+ cells into three distinct 
subsets, CD11b+Ly6Chi, CD11b+Ly6Cint, and CD11b+Ly6Clo. 
CD11b+Ly6Chi cells are usually considered as inflammatory 
monocytes that are negative for MHC-II and Ly6G (32), and we 
found them being underrepresented in the oral mucosa relative to 
spleen and lung (Figure 3A, bottom; Figure S3C in Supplementary 
Material). On the other hand, we observed a marked increase in 
CD11b+Ly6Clo cells, which corresponded to resident monocyte/
macrophages (Figure 3B, bottom) (33). Thus, the oral mucosa is 
highly enriched in CD11b+ and/or CD11c+ APCs of myeloid ori-
gin, and specifically enriched in monocytes of the tissue-resident 
CD11b+Ly6Clo phenotype. In this regard, the oral mucosa is 
similar to lung mucosa (Figure S3C in Supplementary Material). 
To further assess if tissue residency and recruitment of distinct 
monocyte subsets is dependent on lymphocytes, we analyzed 
the oral mucosa of Rag-deficient mice (RAGKO). We did not 
observe noticeable differences between wild-type (WT) B6 mice 
and RAGKO mice (Figure  3C), indicating that the monocyte 
population in the oral mucosa is maintained independently of 
the adaptive immune system.
Tissue residency of Oral Mucosal 
lymphocytes
To understand the immune status of oral mucosa T cells, next, we 
examined activation marker expression on CD4 and CD8 T cells. 
CD44 is a widely used activation marker that is highly induced 
upon TCR stimulation and memory phenotype differentiation 
(34). We found that most CD8 T cells in the oral mucosa were 
CD44lo and only a small fraction was CD44hi (Figure 4A, bottom). 
In contrast, a large fraction of oral mucosa CD4 T cells expressed 
high levels of CD44 (Figure  4A, top) and, interestingly, also 
the acute activation marker CD69 (Figure  4B, left). Moreover, 
many of the CD69+ CD4 T cells in the oral mucosa co-expressed 
CD103 (Figures 4B,C), an integrin with tissue retention function 
that binds to E-cadherin on epithelial cells (35). Co-expression 
of CD69 and CD103 is considered a hallmark of tissue-resident 
memory cells that have alarming function and serve as first 
responders to pathogens on site of infection (36, 37). Thus, these 
results showed that CD4 T cells with a tissue-resident CD103+ 
CD69+ phenotype were highly enriched in the oral mucosa, but 
interestingly not in the spleen and lung (Figure 4B, top; Figure 
S3D top in Supplementary Material). In contrast, CD103+CD69+ 
memory phenotype CD8 T  cells, which accumulate in the gut 
mucosa (Figure  4B, bottom; Figure  4C), were conspicuously 
absent in the oral mucosa. In fact, CD103+CD69+ CD8 T cells 
were only found among SI IELs and were not represented in sig-
nificant numbers neither in the spleen nor lung mucosa (Figure 
S3D bottom in Supplementary Material). These results suggested 
that either the oral mucosa lacks tissue-resident memory phe-
notype CD8 T cells or the tissue residency in the oral mucosa is 
independent of CD69 and CD103 expression.
Consequently, we wished to know if the oral mucosa contains 
tissue-resident CD8 T cells. To test this idea, we injected WT mice 
with the S1P1 receptor antagonist FTY720, which inhibits circu-
lation of T cells and traps them in the LN (38). Indeed, FTY720 
injection resulted in decreased T cell numbers in the spleen but 
retention of T cells in the LN (Figure 5A). In the oral mucosa, 
we found a significant decrease (~50%) in both αβ and γδ T cell 
frequencies upon FTY720 treatment (Figures  5B,C). Contrary 
to our expectation, however, we did not find increased accumu-
lation of CD4 T cells, which we had considered tissue resident 
based on their CD69 and CD103 expression (Figure 5B, bottom). 
Instead, we found a significant increase in CD8 T cell frequency 
that remained tissue resident, despite being mostly absent for 
surface CD69 and CD103 co-expression. Consequently, FTY720 
treatment markedly reduced the CD4/CD8 ratio of αβ T  cells 
in the oral mucosa (Figure 5D). Moreover, the remaining CD8 
T cells still did not show upregulation of CD69, which would have 
been necessary to prevent S1P1 signaling (Figure 5E) (39). These 
FigUre 2 | lymphocyte subsets in the oral mucosa. (a) B220+ and CD3+ cell frequencies in CD45+-gated cells from the oral mucosa. Results are 
representative of three independent experiments. (B) T cell frequencies (top) and CD4/CD8 ratios (bottom) in the indicated organs. Results are representative and 
the bar graphs show summary of seven independent experiments. (c) CD4/CD8 ratio (top) and CD8α, CD8β analysis of CD45+TCRβ+ cells in the oral mucosa and 
small intestine intraepithelial leukocyte (SI IEL) (bottom). Results are representative of three independent experiments. (D) Invariant NKT (iNKT) cells were identified in 
the oral mucosa and spleen using PBS57-loaded CD1d tetramers (top) and empty-CD1d tetramers as control (bottom). Results are representative of three 
independent experiments. (e) γδ T cells (top) and NK cells (bottom) in the oral mucosa and spleen. Results are representative of three independent experiments. 
Oral mucosa tissues were processed under identical conditions, using the SDTL protocol outlined in Figure S2 in Supplementary Material.
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FigUre 3 | Myeloid cell subsets in the oral mucosa. (a) CD11b, CD11c, and Ly6C expression on CD45+-gated non-B, non-T cells in the indicated organs. 
Results are representative of five independent experiments. (B) Frequencies of CD11b+, CD11c+, and CD11b+Ly6Clo cells in the oral mucosa. Data show summary 
of five independent experiments. (c) CD11b, CD11c, and Ly6C expression on CD45+-gated non-B, non-T cells in the oral mucosa of wild-type (WT) and RAGKO 
mice. Results are representative of three independent experiments.
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data indicated that tissue residency of CD8 T  cells in the oral 
mucosa is controlled by mechanisms other than, or in addition 
to, conventional CD103 and CD69/S1P1 receptor-dependent 
mechanisms. Deciphering the molecular basis for these observa-
tions will contribute to our further understanding of immune 
surveillance and homeostasis in the oral mucosa.
FigUre 4 | expression of tissue retention molecules on oral mucosa 
T cells. (a) Surface CD44 expression on CD4 and CD8 T cells of spleen and 
oral mucosa. Results are representative of four independent experiments. 
(B) Surface CD69 and CD103 expression on CD4+ (top) and CD8+ T cells 
(bottom) isolated from the indicated organs. Results are representative of five 
independent experiments. (c) Frequency of CD103+CD69+ cells among CD4 
and CD8 T cells in the indicated organs. Bar graphs show summary of five 
independent experiments.
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DiscUssiOn
Oral mucosal immunity is critical for host defense and local tissue 
protection and also plays an essential role in maintenance and 
surveillance of the microbiota in the oral cavity. Nonetheless, 
the immune cell subsets and their functions involved in these 
processes have remained mostly uncharacterized. A major 
obstacle to address these issues has been the lack of a reliable 
and reproducible method to isolate immune cells from the oral 
mucosa. Here, we established a cell isolation protocol that utilizes 
a staggered treatment of two different proteolytic enzymes and 
collagenases, followed by a 40/70% Percoll gradient. Using this 
method, which we refer to as the SDTL protocol, we found all 
major lymphocyte populations, i.e., T-, B- cells, and γδ T cells, 
being represented in the oral mucosa, but observed a conspicuous 
absence of iNKT cells. Whether this is a failure to recruit or to 
retain iNKT  cells in these tissues needs further investigations. 
In addition to lymphocytes, we also detected a large fraction of 
myeloid origin cells among CD45+ leukocytes in the oral mucosa. 
Using the surface markers integrin CD11c and CD11b, we identi-
fied distinct dendritic cell and macrophage subsets, which showed 
marked differences in their distribution not only compared to 
SLOs in the periphery but also to the mucosal tissue in the gut 
and lung. We chose to compare the oral mucosa to the gut and 
lung mucosa because the oral cavity represents the most proximal 
extent of the respiratory (lung) and digestive system (gut) (40), 
and thus face similar antigenic and environmental challenges. 
The skin also represents a major protective barrier tissue, but it is 
structurally dissimilar to the oral mucosa as it contains adnexal 
structures, such as hair follicles and sweat glands, and shows 
distinct patterns of keratinization, so it was excluded from the 
current analysis (10). Altogether, our results paint a new and 
more complete picture of the immune cell composition in the 
oral mucosa than which was available before.
Of note, we need to emphasize that our current data have 
been acquired from the entire oral mucosa and not from 
distinct locations within the oral cavity. It is well documented 
that the composition and function of immune cells can dif-
fer depending on the anatomical area, so dendritic cells or 
macrophage-like APCs in the sublingual or buccal area have 
specialized functions and phenotypes compared to cells in 
other parts of the oral mucosa (21, 40, 41). As such, our study 
rather describes the collective immune cell composition of the 
oral mucosa, and we aim to address the cellular composition 
of specific compartments in future studies. Nonetheless, our 
findings were informative as it discovered the lack of CD8αα 
T cells in the oral mucosa, which illustrated a marked difference 
to the gut mucosa, and also revealed the unique presence of 
CD103+CD69+ tissue-resident phenotype CD4+ T cells, which 
differed from spleen and other SLOs. Collectively, the oral 
mucosa represents a unique site of immune cell distribution 
that requires further investigations to understand its role in 
host protection and immune pathology.
Effective recovery of immune cells from the oral mucosa is 
a daunting task, because cells are embedded in tissues and stay 
in close contact with stromal cells. Mechanical dissociation 
often results in cell damage and death. Enzymatic digestion of 
FigUre 5 | Tissue residency of oral mucosal lymphocytes. (a) αβ T cell numbers in spleen and lymph node (LN) of FTY720-treated mice. Single cell 
suspension of spleen and LN were assessed for T and B cell surface markers and used to determine cell numbers. Results are summary of two independent 
experiments with each five mice for FTY720 and vehicle-injected mice. (B) Phenotype of oral mucosal lymphocytes in FTY720-adminstered mice. Results are 
representative of two independent experiments with each five mice for FTY720 and vehicle-injected mice. (c,D) Frequency and CD4/CD8 ratio of αβ T cells in the 
oral mucosa upon FTY720 administration. Results show summary of three independent experiments with each 15 mice for FTY720 and 10 mice for vehicle control 
(water) injection. (e) CD69 surface expression on CD8 T cells upon FTY-720 or vehicle control administration. Dot plots are representative of two independent 
experiments. Bar graph shows frequencies of CD69+ cells among CD8 T cells as mean ± SEM.
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the connective tissue using collagenase, on the other hand, is a 
gentler method, but it can also result in degradation of surface 
proteins on immune cells. Collagenase is a collective term for 
proteases that specifically recognizes the amino acid sequence 
Pro–X–Gly–Pro, of which X refers to a neutral amino acid (42). 
The Pro–X–Gly–Pro motif is frequently found in collagen but not 
in other proteins, so collagenase treatment results in preferential 
deconstruction of the collagen-rich cell matrix with minimal 
effects on lymphocytes. While type IV or H collagenase has been 
routinely used in tissue digestion (25, 43), in our hands, colla-
genase IV or H were unsatisfactory for the oral mucosa because 
it resulted in low efficiency cell recovery. Instead, we found that a 
mixture of collagenase I and II, which is commercially available 
as a reagent called “Liberase,” was more effective in degrading 
the tissue matrix. Moreover, we found that the addition of small 
amounts of the neutral protease dispase markedly increased cell 
recovery, which was further improved by an additional step of the 
neutral protease thermolysin. We verified the efficacy and preser-
vation of surface antigens by treating spleen and LN tissues with 
the same protocol and by comparing isolated lymphocytes with 
procedure to cells that were isolated using conventional methods. 
Collectively, the staggered neutral protease treatment in the pres-
ence of Liberase enabled isolation and analysis of immune cells 
from the oral mucosa with high efficiency and reproducibility.
9Park et al. Lymphocyte Isolation from the Oral Mucosa
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Antigenic insult or pathogen invasion can trigger dramatic 
remodeling of the immune architecture, resulting in rapid influx 
and efflux of migratory cells into the oral mucosa. Interestingly, 
significant fractions of T cells are tissue resident and remain on 
site even after mobilizing signals (16, 44). The importance of 
tissue-resident T  cells has been recently demonstrated in their 
role of sensing pathogens and alarming other immune cells, 
specifically in barrier tissues, such as the skin, lung, and the gut 
(36, 37). Tissue-resident T cells are marked by co-expression of 
the cell adhesion molecule CD103 and the activation marker 
CD69, which inhibits surface transport of the S1P1 receptor 
(45). S1P1 receptor expression is necessary for T cells to undergo 
chemotaxis in response to the sphingosine-derived lipid S1P, 
which is expressed in high concentration in the blood and thus 
draws T cells into circulation (44). Notably, we found a large frac-
tion of oral mucosal CD4 T cells to co-express CD103 and CD69, 
suggesting them to be tissue-resident. Oral mucosal CD8 T cells, 
on the other hand, were mostly absent for CD103+CD69+ T cells, 
which differed from the gut where the vast majority of CD8αβ 
T cells are CD103+CD69+ tissue-resident cells (16). Interestingly, 
FTY720 administrations revealed that a large fraction of CD8 
T  cells was still tissue resident, even without co-expression of 
CD103 and CD69. These results suggested that, at least in the 
oral mucosa, CD103 and CD69 expression is not a requirement 
to impose tissue residency for T cells. Notably, a recent study also 
reported a CD69-independent retention of tissue-resident CD8 
T cells in the lung, indicating that the phenotype and retention 
mechanisms of resident memory T cells might vary depending on 
the tissue environment (46).
Collectively, this study reports the immune cell composition and 
distribution of the oral mucosa under homeostatic conditions and 
thus opens up new questions on the activation and tissue residency 
of these cells. Utilizing the new cell isolation protocol, we expect 
that these inquires can be effectively answered in future studies.
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